OtherBehavioral Pharmacology
The NR2B-selective NMDA receptor antagonist Ro 25-6981 potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens
Alexander R Kosowski and Sture Liljequist
Journal of Pharmacology and Experimental Therapeutics July 15, 2004, DOI: https://doi.org/10.1124/jpet.104.070235
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherBehavioral Pharmacology
The NR2B-selective NMDA receptor antagonist Ro 25-6981 potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens
Alexander R Kosowski and Sture Liljequist
Journal of Pharmacology and Experimental Therapeutics July 15, 2004, DOI: https://doi.org/10.1124/jpet.104.070235
OtherBehavioral Pharmacology
The NR2B-selective NMDA receptor antagonist Ro 25-6981 potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens
Alexander R Kosowski and Sture Liljequist
Journal of Pharmacology and Experimental Therapeutics July 15, 2004, DOI: https://doi.org/10.1124/jpet.104.070235
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement